Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes
Non-muscle-invasive bladder cancer (NMIBC) patients receive frequent monitoring because ≥ 70% will have recurrent disease. However, screening is invasive, expensive, and associated with significant morbidity m...